We present three unrelated Korean Shwachman-Diamond syndrome (SDS) patients that carry an incomplete but identical homozygous EFL1 p.Thr1069Ala variant due to a bone marrow-specific mosaic uniparental disomy (UPD) in chromosome 15. This rare variant is found in 0.017% of East Asians and is asymptomatic in a heterozygous status, but harbors a hypomorphic effect, leading to reduced 80S ribosome assembly of ribosomal protein (RP) transcripts. We propose a novel somaticallyinduced pathogenesis mechanism and EFL1 dysfunction that eventually leads to aberrant translational control and ribosomopathy. SDS (OMIM: #260400) presents with hematologic manifestations, exocrine pancreatic dysfunction with fatty infiltration, and skeletal dysplasia resulting in short stature 1 . SDS is mostly caused by variants in SBDS (Shwachman-Bodian-Diamond syndrome gene), encoding a protein that plays an important role in ribosome assembly 1-5 . However, 10-20% of the cases clinically diagnosed with SDS do not harbor pathogenic variants in the gene, suggesting the existence of additional genetic mechanisms that lead to the disorder 1,3 . Recent reports demonstrated that variants in DNAJC21 and SRP54 are implicated with bone marrow failure syndrome and SDS 6-8 , meanwhile, another report suggested that homozygous mutations in elongation factor-like GTPase 1 (EFL1) causes a SDS-like syndrome 9 . Given the known role of EFL1 in a direct interaction with SBDS that releases eukaryotic translation initiation factor 6 (eIF6) from the 60S ribosomal subunit for 80S ribosomal assembly 4,10 , it is plausible that functional abnormalities in
EFL1 cause diseases similar to SDS. However, detailed molecular mechanisms and in vivo evidence that the impaired EFL1 causes SDS-like features are still limited.
We exome-sequenced three unrelated and non-consanguineous Korean SDS patients without plausible mutations in SBDS (Supplementary   Tables 1 and 2 , Fig. 1a and Supplementary Fig. 1 ). The heterozygous p.Thr1069Ala variant of EFL1 (chr15:82,422,872 T>C, hg19, NM_024580.5:c.3205A>G) was identified in all three patients (Supplementary Table 3 , Fig. 1b ). It is a low frequency variant, carried by three individuals among 17,972 alleles of the East Asian population in gnomAD (allele frequency (AF) = 1.67 x 10 -4 ) 11 . It was noted that the variant allele of I-1 and II-1 was dominantly covered compared to the reference allele (86.5 and 77.6%, respectively), making it function like an incomplete homozygous variant, while the ratio was comparable in III-1 (41.1%, Fig. 1c) . Surprisingly, all patients carried a partial loss-of-heterozygosity (LOH) in chromosome 15, where EFL1 locates (Fig 1d, Supplementary Figs. 2 and 3 ). This LOH was copy-neutral and not seen in healthy parents ( Supplementary Fig. 4 ), suggesting that it was caused by somatic UPD. Furthermore, homozygosity of the EFL1 locus is not frequently found in healthy Korean individuals (1/3,667, Supplementary Fig. 5 ). The sizes of the LOH internals were variable among the patients (100, 100 and 27.8% of the entire chromosome span, respectively; Fig. 1d ). To test if the UPD event occurred in a mosaic pattern and whether LOH-carrying and non-LOH-carrying cells co-exist, single-cell SNP microarray was performed using bone marrow (I-1) or buccal swabbed epithelial cells (III-1). As expected, complete LOHs in chromosome 15 were observed in a subset of the cells, confirming mosaic UPD events ( Supplementary Fig. 6 ). Therefore, those cells having UPD of chromosome 15 are expected to be EFL1 p.Thr1069Ala/p.Thr1069Ala . II-1 could not be tested due to sample unavailability. Next, we checked the spatial extent of the mosaic UPD by subjecting all available tissue samples of I-1 into a high-depth amplicon sequencing analysis (>40,000X coverage depths). Variant AFs of p.Thr1069Ala in I-1 were ~0.85 in peripheral blood and bone marrow, while ~0.5 in most tissues, suggesting that the mosaic UPD is restricted at least to the bone marrow ( Fig. 1e ). These results were concordant with Sanger sequencing results ( Supplementary Figs. 7 and 8 ). The degree of mosaicism of bone marrow tissue changed dynamically over the time course on I-1, without displaying a strong correlation with the clinical status of the patient ( Supplementary Fig. 9 ). The variant residue lies in the C-terminus of the protein and is highly conserved throughout evolution ( Fig. 1f ). EFL1 protein structure analysis suggests that the p.Thr1069 residue is engaged in hydrogen bonding with p.Gln884, which is presumably involved in stabilizing the protein structure ( Fig. 1g and Supplementary Fig. 10 ). Since EFL1 is known to mediate GTP hydrolysis-coupled eukaryotic translation initiation factor 6 (eIF6) release together with SBDS in maturation of the 60S ribosome subunit 4,10 , we observed the ribosomal assembly status of wild-type, siRNAor CRISPR/Cas9-mediated ablation of EFL1 (EFL1 KD or EFL1 -/-) in HeLa and K562 cell lines to further elucidate the molecular mechanism of the mutant protein function. Polysome profiling of EFL1 KD and EFL1 -/cells showed a significantly reduced 80S peak ( Fig. 1h and Supplementary Fig. 11 ). This abnormal polysome profile was completely rescued after introduction of FLAG-tagged wild-type EFL1 (EFL1 -/--WT), but not by the mutant EFL1 (EFL1 -/--T1069A; Fig. 1i and Supplementary Fig. 12 ). These results indicate that EFL1 plays a crucial role in ribosome assembly and that the EFL1 p.Thr1069Ala is hypomorphic. To validate these observations in vivo, a morpholino-targeting zebrafish model of efl1 was subjected to rescue experiments ( Supplementary Figs. 13a-b ). efl1 morphants have smaller head and eyes as wells as a slightly bent tail (Fig. 1i ), and display an increased number of apoptotic cells during development ( Supplementary Fig. 13c ). Both primitive erythrocytes and granulocytes were significantly reduced in efl1 morphants, indicating impaired primitive hematopoiesis in these embryos ( Fig.   1j , k, and Supplementary Fig. 13d ). All the phenotypes were rescued by the introduction of wild type mRNA, but less so by the mutated mRNAs (Figs. 1i-k), confirming that the abnormal degree of efl1 activity causes SDS-like features in vivo.
We then investigated the molecular mechanism of the variant in ribosome assembly. The variant function was not mediated via phosphorylation of p.Thr1069, aberrant subcellular localization, or changes in binding affinity with SBDS ( Supplementary Figs. 14 and 15 ). Next, measuring eIF6 level from each ribosome subunit-bound fraction revealed that it was more enriched in 40S and 60S ribosome fractions of EFL1 -/or EFL1 -/--T1069A ( Fig. 2a and Supplementary Fig. 15 ) compared to wild-type or EFL1 -/--WT. This result, along with an observation that eIF6 and SBDS changes did not stem from a transcription level ( Supplementary Fig. 16 ), implies that blocked exclusion of eIF6 and SBDS from a 60S ribosomal subunit is one of the mechanisms of our mutant protein action, and results in impaired 80S ribosome assembly. To further investigate features of downstream genes that are heavily affected by the reduced function of EFL1, we performed RNA sequencing on fractions from total RNA, 40S-, 80S-and polysome-bound RNAs from wild-type and EFL1 knockout K562 cells ( Fig. 2b and Supplementary Fig. 17 ). The 248 genes that were decreased in the 80Sbound compared to the 40S-bound fraction in the mutant cells were extracted and a gene ontology analysis strongly suggests that ribosomal protein (RP) genes (GO:0003735) are the major constituents of the genes that were influenced by the absence of EFL1 (P adj = 5.2 x 10 -77 ; Fig. 2c ). There was no significantly enriched gene group in the increased 80S/40S genes. The fractions of transcripts bound by 40S-, 80S-or polysome differ substantially for the RP genes by the absence of EFL1 (Wilcoxon signed-rank test, P < 1.0 x 10 -13 for differences in both 40S-and 80S-bound transcripts), whereas TP53 target genes (n = 65) or all other genes did not show such change ( Fig. 2d , P > 0.05). To elucidate the mechanism of RP-specific regulation, we sought to compare whether transcript sizes ( Supplementary Fig. 18 ), expression levels, or consensus sequence elements in 5' UTRs may function as determining factors. Notably, highly-expressed RP transcripts with a terminal oligo-pyrimidine (TOP) element (5'-CUUYCUUUUNS-3') were specifically altered ( Fig. 2f and Supplementary Fig. 19 ; P = 6.9 x 10 -7 ). Subsequent western blotting of selected RPs confirmed reduced protein synthesis in EFL1 -/cells ( Fig. 2g and Supplementary Fig. 20) .
Assessing the functionality of variants of unknown significance poses a major hurdle in genetic studies. Here we demonstrate a process where an apparently benign, but hypomorphic variant gains pathogenicity through somatic UPD. EFL1-mutated patients arise in a recessive manner 9 , and heterozygous LoF variants do not cause any defect (gnomAD pLI = 0.00), which suggests that a UPD-derived homozygous p.Thr1069Ala variant drives the protein function below a clinical threshold. According to a recent survey of haematopoietic chromosomal mosaicism events, 117 individuals carried copy-neutral or deletion of the EFL1 locus among 151,202 apparently normal individuals. Multiplying this to the AF of the p.Thr1069Ala produces 1.30 x 10 -7 , which is not too divergent from our odds of observing three patients from the population of Korea, with a centralized medical referral system 12 . The degrees of mosaicism in the three patients varied substantially (Fig. 1d) , and does not seem to determine clinical severity ( Supplementary Fig. 10 ).
Nonetheless, an altered function of EFL1 specifically influenced translation of RP genes with a TOP element, which leads to the mechanistic mimicry of Diamond-Blackfan anemia (DBA), another ribosomopathy caused by insufficient RP dose 13 (Fig 2f and Supplementary Fig. 17 ). Activation of TP53 has been considered as a targetable downstream pathway that leads to SDS or a DBA phenotype [14] [15] [16] . But our data suggest that loss of EFL1 does not induce TP53 activation, which is consistent with the previous zebrafish sbds model ( Fig. 2e) 17 . Here we introduce a mechanism where a somaticallyinduced mosaic mutation in EFL1 converted an apparently benign rare variant into a pathogenic one, and phenocopies classical SDS in three unrelated patients. We demonstrated that the defective EFL1 causes 
